ScholarIQanswers from OpenAlex

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease

PaperCitations, authors & open-access status

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease have?

ScholarIQcitation count

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease has 63 citations in the OpenAlex counts ScholarIQ stores.

When was Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease published?

ScholarIQyear

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease has 2014 year in the ScholarIQ index.

What is the open-access status of Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease?

ScholarIQoa status

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease has hybrid oa status in the ScholarIQ index.

What is the DOI of Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease?

ScholarIQdoi

The DOI for Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease is on the source record.

What is the PMID of Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease?

ScholarIQpmid

The PMID for Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease is on the source record.

What is the OpenAlex record for Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease?

ScholarIQopenalex

The OpenAlex for Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial